Interleukin 12 delays allograft rejection: effect mediated via nitric oxide.
Verma
N
N
Department of Medicine, Liverpool Hospital and University of New South Wales, NSW, Liverpool, Australia.
He
X Y
XY
Chen
J
J
Robinson
C
C
Boyd
R
R
Tran
G
G
Hall
B M
BM
D000276:Adjuvants, Immunologic / Q000235:genetics / Q000494:pharmacology*; D000818:Animals; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006084:Graft Rejection / Q000517:prevention & control*; D006085:Graft Survival / Q000187:drug effects*; D016027:Heart Transplantation; D018664:Interleukin-12 / Q000235:genetics / Q000494:pharmacology*; D008239:Lysine / Q000031:analogs & derivatives / Q000494:pharmacology; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D052247:Nitric Oxide Synthase Type II; D051381:Rats; D014184:Transplantation, Homologous
D000276:Adjuvants, Immunologic; D004791:Enzyme Inhibitors; C090663:N(6)-(1-iminoethyl)lysine; D018664:Interleukin-12; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II; C496318:Nos2 protein, rat; D008239:Lysine